Quick Answer
Prestige Consumer Healthcare Inc. reported Diluted EPS of $4.29 per share for fiscal year 2025.
Prestige Consumer Healthcare Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $4.29 | +2.9% |
| 2024 | $4.17 | +352.7% |
| 2023 | -$1.65 | -140.8% |
| 2022 | $4.04 | +24.3% |
| 2021 | $3.25 | +16.9% |
| 2020 | $2.78 | +502.9% |
| 2019 | -$0.69 | -110.9% |
| 2018 | $6.34 | +387.7% |
| 2017 | $1.30 | -30.9% |
| 2016 | $1.88 | +26.2% |
| 2015 | $1.49 | +7.2% |
| 2014 | $1.39 | +9.4% |
| 2013 | $1.27 | +74.0% |
| 2012 | $0.73 | +25.9% |
| 2011 | $0.58 | -9.4% |
| 2010 | $0.64 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.97 | -20.5% | +12.8% |
| September 30, 2025 | $0.86 | -21.1% | -9.5% |
| June 30, 2025 | $0.95 | -3.1% | -22.1% |
| December 31, 2024 | $1.22 | +15.1% | +11.9% |
| September 30, 2024 | $1.09 | +1.9% | +11.2% |
| June 30, 2024 | $0.98 | -7.5% | -7.5% |
| December 31, 2023 | $1.06 | +1.9% | -0.9% |
| September 30, 2023 | $1.07 | +4.9% | +0.9% |
- Prestige Consumer Healthcare Inc. showed an increase of +2.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, Prestige Consumer Healthcare Inc.’s diluted eps has grown by 570.3% (from $0.64 per share to $4.29 per share).
- The most recent figure is from Prestige Consumer Healthcare Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 9, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: